24th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170165356 | HYBRID CORE FELINE VACCINES - The present invention relates to a hybrid vaccine for protecting a feline against diseases associated with respiratory diseases. The vaccine commonly includes a feline antigen. Methods for protecting felines against diseases associated with feline gastrointestinal and respiratory diseases, including but not limited to feline calicivirus, feline rhinotracheitis and feline panleukopenia, and methods of producing the feline vaccine are also provided. | 2017-06-15 |
20170165357 | Immunotherapy Composition and Use Thereof - The present invention relates to the field of preventing or reducing incidence or severity of an allergic immune response, and compositions for preventing or reducing incidence or severity of an allergic immune response. For example, the present invention provides compositions comprising inactivated and/or killed cells of | 2017-06-15 |
20170165358 | METHODS FOR ENHANCING THE IMMUNOSTIMULATION POTENCY OF ALUMINUM SALT-ABSORBED VACCINES - Provided herein are (1) a method of mixing an aluminum salt-adsorbed immunogen with a monophosphoryl lipid A (MPLA)-containing liposome (L(MPLA)), and (2) the resulting immunogenic composition. The resulting immunogenic composition has an enhanced immunostimulation potency compared with either a composition comprising the uncapsulated immunogen mixed with the L(MPLA) or the aluminum salt-adsorbed immunogen alone. | 2017-06-15 |
20170165359 | IMMUNOSTIMULATORY COMBINATIONS OF TLR LIGANDS AND METHODS OF USE - The present invention provides immunostimulatory combinations of TLR ligands and therapeutic and/or prophylactic methods that include administering an immunostimulatory combination to a subject. In general, the immunostimulatory combinations described herein can provide an increased immune response compared to other immunostimulatory combinations and/or compositions. | 2017-06-15 |
20170165360 | Methods of Treating Autoimmune Diseases - Novel methods for treating patients with autoimmune diseases are disclosed. The methods of the invention include first depleting circulating lymphocytes in the mammal, e.g., by administering anti-thymocyte antibody, and then, during the course of repopulation, administering to the mammal a therapeutically effective amount of latent TGF-β and/or another agent that promotes expansion of regulatory T cells. In certain aspects, the disclosed process results in improved kidney function and survival rates. | 2017-06-15 |
20170165361 | TREATMENT OF LYSOSOMAL DISORDERS (ANTI-TNF THERAPY) - The invention relates to methods for treating a Lysosomal storage disease (LSD) in a patient. Kits for use in such methods are also provided. | 2017-06-15 |
20170165362 | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ARGINYL-TRNA SYNTHETASES - Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements thereof, related agents, and methods of use thereof in diagnostic, drug discovery, research, and therapeutic applications. | 2017-06-15 |
20170165363 | CANCER CELL MIGRATION INHIBITORS AND THEIR USE IN THERAPEUTIC TREATMENTS - Described are methods of treating or preventing cancer in patients by administering Interleukin 6 (IL-6) inhibitor and Interleukin 8 (IL-8) inhibitor, in a concentration ratio range to inhibit the migration of cancer cells. | 2017-06-15 |
20170165364 | THERAPEUTIC AGENT FOR SOLID CANCER - Disclosed is a novel means effective for treatment, metastasis-inhibition, and recurrence-inhibition of human solid cancer. A therapeutic agent for solid cancer according to the present invention comprises as an effective ingredient an anti-CD4 antibody having a high cytotoxic activity, or an anti-CD4 antibody or antigen-binding fragment thereof which antibody or fragment comprises a cytotoxic component bound thereto. Said anti-CD4 antibody is a human-type chimeric antibody, humanized antibody or human antibody against human CD4. The therapeutic agent of the present invention produces still higher effects by combined use with antagonist or agonist against immune checkpoint molecule, small molecule anticancer agents, or the like. The therapeutic agent is also effective in suppressing recurrence and metastasis of solid cancer. | 2017-06-15 |
20170165365 | HUMANIZED PAN-HER ANTIBODY COMPOSITIONS - The invention relates to humanized recombinant antibodies targeting the EGFR family receptors EGFR, HER2 and HER3, compositions comprising at least one humanized anti-EGFR antibody, at least one humanized anti-HER2 antibody and at least one humanized anti-HER3 antibody, and use of the antibody compositions for treatment of cancer. The invention also relates to the use of antibodies targeting multiple EGFR-family receptors to treat cancer (e.g., pancreatic cancer) and cancer that has acquired resistance to previous therapies. | 2017-06-15 |
20170165366 | Anti-TIGIT Antigen-Binding Proteins and Methods of Use Thereof - Provided herein are antigen-binding proteins (ABPs) that selectively bind to TIGIT and its isoforms and homologs, and compositions comprising the ABPs. Also provided are methods of using the ABPs, such as therapeutic and diagnostic methods. | 2017-06-15 |
20170165367 | COMPOSITIONS COMPRISING SALBUTAMOL SULPHATE - A pharmaceutical composition is described that is suitable for delivery from a pressurised container. The composition is free of polar excipients and comprises: (a) a propellant component that consists essentially of 1,1-difluoroethane (R-152a); (b) a surfactant component that comprises oleic acid; and (c) a drug component that consists of salbutamol sulphate. The pharmaceutical composition can be delivered using a metered dose inhaler (MDI). | 2017-06-15 |
20170165368 | METHOD FOR TREATING RETINAL CONDITIONS USING AN INTRAOCULAR TAMPONADE - Composition comprising at least one fatty acid glycerol ester for use during or after a vitrectomy procedure, said composition being bioresorbable, being injectable in the vitreous cavity, having a density below 1, more preferably comprised between 0.90 and 1, or a density above 1 more preferably between 1 and 1.5; having a surface tension of less than 50 dynes/cm more preferably ranging from 20 and 30 dynes/cm, being not susceptible to emulsify into droplets when injected; method for treating a retinal disorder involving the use of said composition. | 2017-06-15 |
20170165369 | METHOD OF TREATING CANCER - The invention provides a method for treating cancer using a coadministration strategy that combines local codelivery of a therapeutic agent and an intracellular penetration enhancing agent, and optionally in further combination with local administration of an immunotherapeutic agent, such as a cancer vaccine or NKT agonist. The invention also provides a method for treating cancer using an intracellular penetration enhancing agent. The methods of the invention aim to substantially kill and/or destroy the target tumor cells, as well as those cancerous cells that have metastasized to other parts of the body. | 2017-06-15 |
20170165370 | ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER - The present invention concerns improved methods and compositions for preparing SN-38 conjugates of proteins or peptides, preferably immunoconjugates of antibodies or antigen-binding antibody fragments. More preferably, the SN-38 is attached to the antibody or antibody fragment using a CL2A linker, with 1-12, more preferably 6 or less, most preferably 1-5 SN-38 moieties per antibody or antibody fragment. Most preferably, the immunoconjugate is prepared in large scale batches, with various modifications to the reaction scheme to optimize yield and recovery in large scale. Other embodiments concern optimized dosages and/or schedules of administration of immunoconjugate to maximize efficacy for disease treatment and minimize side effects of administration. | 2017-06-15 |
20170165371 | NOVEL SYNTHESIS OF POTENTIAL ESTER PRODRUGS - Esters prodrugs that cross the blood brain barrier can be ideal drugs for treatment of diseases of the central nervous system because the cerebral spinal fluid contains an abundance of esterases. The prodrug can be hydrolyzed into an active drug and a metabolite such as cholesterol that is known to be non-toxic and is familiar to the central nervous system. This invention describes a modification of the Fischer-Speier or Fischer esterification reaction in which one reagent is lipophilic and the other reagent is hydrophilic. The reaction occurs in a heterogeneous mixture. The preferred catalyst is 1.0 M hydrochloric acid and the preferred solvent is acetone. The presence of ester synthesis was confirmed by the hydroxamic acid-ferric perchlorate reaction. The synthesis can be conducted without chemical scaffolds and without protecting functional groups. | 2017-06-15 |
20170165372 | N-OPTIONALLY SUBSTITUTED ARYL-2-OLIGOMER-3-ALKOXYPROPIONAMIDES - The invention relates to (among other things) N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides and compositions comprising the same. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer. | 2017-06-15 |
20170165373 | BCMA ANTIGEN BINDING PROTEINS - The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates. | 2017-06-15 |
20170165374 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS - Provided herein are pharmaceutical compositions comprising an antibiotic encapsulated in liposomes. The lipid membrane component of the liposomes, or portion thereof comprises an unsaturated phospholipid. The antibiotic-to-lipid component weight ratio of the liposomes ranges from about 0.5-to-1 to about 3-to-1. The pharmaceutical compositions in some embodiments also include free antibiotic, in addition to encapsulated antibiotic. Methods for treating bacterial infections, e.g., pulmonary bacterial infections such as nontuberculous mycobacterial infections with the pharmaceutical compositions are also provided. | 2017-06-15 |
20170165375 | ANTIBIOTIC PROTOCELLS AND RELATED PHARMACEUTICAL FORMULATIONS AND METHODS OF TREATMENT - The invention provides novel antibiotic protocells comprising mesoporous nanoparticles encapsulated within a lipid bi- or multilayer. The nanoparticles have pore sizes and surface chemistries that enable facile adsorption and intracellular presentation of antibiotics which are effective in the treatment of a wide variety of bacterial infections, including | 2017-06-15 |
20170165376 | APTAMERS FOR TUMOR INITIATING CELLS - Aptamers consisting of a single stranded nucleic acids having 100 nucleotides or less that specifically binds to tumor initiating cancer cells are described. The aptamers can be identified by screening a large pool of randomly generated aptamers to obtain a discrete set of aptamers that specifically bind to tumor initiating cancer cells, such as those found in brain cancer or glioblastoma. The aptamers can also be linked or complexed with anticancer agents or imaging agents for use in therapy or diagnosis. | 2017-06-15 |
20170165377 | ISOLATION OF NOVEL AAV'S AND USES THEREOF - The invention in some aspects relates to isolated nucleic acids, compositions, and kits useful for identifying adeno-associated viruses in cells. In some aspects, the invention provides kits and methods for producing somatic transgenic animal models using recombinant AAV (rAAV) to an animal having at least one transgene that expresses a small interfering nucleic acid or at least one binding site for a miRNA. | 2017-06-15 |
20170165378 | COMPOSITION FOR TREATING CANCEROUS CELLS AND A METHOD THEREFOR - A composition for treating cancerous cells in a subject having an immune system includes a virus in the | 2017-06-15 |
20170165379 | Endoscopic Mucosal Lift Kit - Method and Product; For use in the human digestive tract for endoscopic submucosal injection, as an aid in identifying the extent and borders of flat mucosal polyps (neoplasia) and creating a dynamic gastrointestinal tract mucosa lift of the surrounding mucosa for a safe and through snare polypectomy. | 2017-06-15 |
20170165380 | Nanosensor Compositions and Methods of use Thereof - Disclosed are compositions comprising a plastic polymer core, a shell surrounding the plastic polymer core, a ligand comprising a binding moiety, an enzyme capable of catalyzing the hydrolysis of a target compound, and a contrast agent, as well as methods of use of such compositions. | 2017-06-15 |
20170165381 | Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease - The present invention relates to new combinations of treatments for abnormal dopamine deficiency disorders, and related conditions, comprising deuterated catecholamine derivatives and catechol-O-methyltransferase (COMT) inhibitors. | 2017-06-15 |
20170165382 | NANOCARRIERS FOR CANCER TREATMENT - The present invention provides conjugates containing metal binding ligands, as well as nanocarriers prepared from the conjugates. | 2017-06-15 |
20170165383 | VARIABLE DOMAINS OF CAMELID HEAVY-CHAIN ANTIBODIES DIRECTED AGAINST GLIAL FIBRILLARY ACIDIC PROTEINS - The present invention relates to the use of variable domains of camelid heavy-chain antibodies (VHH domains) directed against an intracellular target and having an isoelectric point of at least 8.5, for targeting said intracellular target or for the preparation of a peptide vector. Particularly, it concerns VHH domains directed against a glial fibrillary acidic protein and uses thereof for preparing therapeutic or diagnostic agents. | 2017-06-15 |
20170165384 | EX VIVO ANTIMICROBIAL DEVICES AND METHODS - A method and device for destroying and inhibiting exposure to microbes and infection includes a first element and a second element, and a power source. At least one of the elements includes antimicrobial metal, which, when energized by the power source, produces ions that are lethal to microbes. The device can be incorporated into virtually any useful object. During normal use of the object, electrical communication is established between the two elements, causing current supplied from the power source to flow through the antimicrobial metal. The two elements are configured and arranged to ensure that ions flowing from the antimicrobial metal flow through the region in which it is desired to kill microbes. The antimicrobial metal can be on the surface of the element, incorporated into the material making up the element, or provided in any other way that allows the antimicrobial effect to be achieved. | 2017-06-15 |
20170165385 | RADIATION DELIVERY SYSTEM AND METHOD - A method of irradiating a work piece may include forming a cutout recessed from a surface of a light guide, positioning the work piece inside the cutout, irradiating a light input surface of the light guide with UV light, and guiding the UV light from within the light guide through recessed surfaces of the cutout to irradiate the work piece. In this way more uniform irradiation of all curable surfaces of a work piece may be achieved, the energy and time consumed during irradiation of the work piece may be reduced thereby lowering operating costs, and the radiation delivery system may be made more compactly, thereby making it more convenient and practical for daily applications. | 2017-06-15 |
20170165386 | MOBILE ELECTRONIC DEVICE STORAGE AND CHARGING CABINET HAVING STERILIZATION FUNCTION - A mobile electronic device storage and charging cabinet includes a body defining therein an accommodation chamber and carriers with individual storage chambers mounted in the accommodation chamber for storing mobile electronic devices individually, a power supply module consisting of a control system and a connector module and mounted in the accommodation chamber with electrical connectors of the connector module respectively electrically connected to storage mobile electronic devices by cables, and a sterilizer consisting of a germicidal lamp set and power drive module and mounted in the body for killing microorganisms, molds, fungi and unicellular algae that are suspended in the air inside the body and adhered to the surfaces of storage mobile electronic devices with ultraviolet light from ultraviolet lamp tubes of the germicidal lamp set subject to the control of the power drive module, achieving optimal disinfection and sterilization effects and protecting the users from health risks. | 2017-06-15 |
20170165387 | Sanitizer - A sanitizer for sanitizing various surfaces including hands, hardware fixtures appliances, countertops, equipment, utensils and more and more specifically to a chemical-free sanitizer, more specifically to an ozone-free sanitizer and yet more specifically to an electronic sanitizer and yet more specifically to an ion source sanitizer. The present invention relates generally to an ion sanitizer including a controller and at least one ion electrode operationally coupled to the controller and the ion electrode includes a plurality of ion sources spaced 6-51 mm apart The ion sanitizer defines a fixture cavity having a plurality of ion sources each include a point directed toward the fixture cavity. | 2017-06-15 |
20170165388 | Organic Waste Odor Absorber - An organic waste odor absorbing composition for the absorption of odors resulting from decomposing organic waste is disclosed. The composition comprises dried carbon and/or silica based matter, either natural or synthetic. The carbon-based materials consist of 35% to 85% holocellulose and 8% to 30% lignin. The silica-based materials consist of 40% to 80% silica. The materials may be mechanically sized to allow for adequate airflow and surface area exposure to the organic waste. | 2017-06-15 |
20170165389 | AUTOMATED HEAT TRANSFER PRESS AND METHOD FOR AUTOMATED HEAT TRANSFER PRESSING - An automated heat transfer press and method for automated heat transfer pressing provides an electric linear actuator motor that induces an arced translation of a first plate onto a second plate for dye sublimation printing. The arced motion of the first plate enables the first plate to press against the second plate at an angle, rather than a vertical pressing action; whereby adaption to a variously sized and dimensioned substrates is possible. A second link bar adjusts alignment of the second plate with first plate. An electric linear actuator motor manipulates a rod through electrical power. Rod is extended to create linear motion. The rod operatively connects to a hinged arm, applying linear force that causes the hinged arm to displace the first plate at arced motion. A control portion regulates the linear actuator motor to press and release the plates against each other in predetermined temperatures and intervals. | 2017-06-15 |
20170165390 | MICROFLUIDIC DELIVERY CARTRIDGES AND METHODS OF CONNECTING CARTRIDGES WITH MICROFLUIDIC DELIVERY SYSTEMS - A method of connecting a cartridge comprising a fluid composition with a microfluidic delivery system is provided. The method includes the steps of: providing a housing comprising electrical contacts, wherein the electrical contacts of the housing are disposed on a first plane; providing a cartridge comprising a reservoir for containing a fluid composition, a die comprising a nozzle, and electrical contacts that are in electrical communication with the die, wherein the electrical contacts of the cartridge are disposed along a second plane that is parallel with the first plane; and connecting the cartridge with the housing by moving the cartridge in a direction parallel with the second plane toward the housing until the electrical contacts of the cartridge are in electrical communication with the electrical contacts of the housing. | 2017-06-15 |
20170165391 | COMPOSITIONS, DELIVERY SYSTEMS AND REFILLS FOR EMITTING TWO OR MORE COMPOSITIONS - A system for delivering a multi-phase fragrance composition comprises a container having a body forming a reservoir and an opening in communication with the reservoir and a multi-phase composition disposed within the reservoir. The multi-phase composition comprises a water phase composition and an oil phase composition and the water phase composition and the oil phase composition are substantially separated. The water phase composition comprises a water phase fragrance and both water and propylene glycol as water phase solvents. The oil phase composition comprises an oil phase fragrance and isopar M as an oil phase solvent. The system further includes a wick in contact with the water phase composition and the oil phase composition and configured to sequentially emit the water phase composition and the oil phase composition. | 2017-06-15 |
20170165392 | ANNULAR SEPARATOR APPARATUS AND METHOD - An unheated, essential oil diffuser relies on a pressurized air stream to educt oil from a reservoir, followed by separators including separation chambers and an annular channel. The latter is a long channel having an aspect ratio (L/d) of from about 10 to about 120, for length L and thickness d. Thickness d is effective diameter, also known as hydraulic diameter (4 times c.s. area, divided by “wetted” or exposed perimeter), and may be from about 25 to about 100 thousandths of an inch (0.6 to 2.5 mm) across the thin passage, with a target range of from about 55 to 75 mils (0.7 to 1 mm). This geometry provides laminar flow at Reynolds number values less than a few hundred for virtually its complete distance of from under one inch (25 mm) to over three inches (76 mm). | 2017-06-15 |
20170165393 | METHOD AND SYSTEM FOR REMOVING A LIQUID FROM A CONTAINER FOR ACCOMMODATING AN OPHTHALMIC LENS - A method of removing a liquid from a container ( | 2017-06-15 |
20170165394 | MEDICAL DEVICE AND METHOD FOR THE PRODUCTION THEREOF - A medical device in the form of a nonwoven wound dressing includes rotospun fibers including at least one synthetic and bioabsorbable polymer and at least one hydrophilic and/or tissue-adhesive polymer, and a method of producing the medical device including using rotospinning to produce fibers from a fiber raw material including at least one synthetic and bioabsorbable polymer and at least one hydrophilic and/or tissue-adhesive polymer. | 2017-06-15 |
20170165395 | SYSTEMS FOR MANAGING INTIMATE SKIN - Systems for managing intimate skin are described. The systems include a cosmetic product that comprises an applicator and a cosmetic composition disposed within the applicator. The cosmetic composition is solid at room temperature, such that some may describe the cosmetic composition as being in a stick form. | 2017-06-15 |
20170165396 | TOPSHEET LAMINATES WITH TACKIFIER-FREE ADHESIVE - Absorbent articles comprising topsheet laminates bonded with substantially tackifier-free adhesives, wherein the topsheet laminates comprise morphological treatments. | 2017-06-15 |
20170165397 | FILLER COMPOSITION FOR THE TREATMENT OF LIPOATROPHY - The present invention refers to a composition that is useful as a filler for the correction of soft tissue volume loss, for example for the cosmetic treatment of wrinkles, or for the treatment of disorders such as lipoatrophy or lipodystrophy in general, said composition comprising agarose and hyaluronic acid, or a pharmaceutically acceptable salt thereof. The particular interaction that takes place between the two components makes even high concentrations of agarose injectable and tolerable, said high concentrations being particularly useful for ensuring the duration and stability over time of the aesthetic results that are achievable using this filler. | 2017-06-15 |
20170165398 | MODIFIED CERAMICS WITH IMPROVED BIOACTIVITY AND THEIR USE FOR BONE SUBSTITUTE - The present invention concerns ceramics having a modified surface with improved bioactivity, their process of preparation and their use for orthopedics, dentistry or reconstructive surgery, in particular for use as a bone filler. | 2017-06-15 |
20170165399 | METHOD OF MANUFACTURING AN IMPLANTABLE FILM AND PROTHESIS COMPRISING SUCH A FILM - A method for manufacturing an implantable film and a prosthesis comprising such a film The present invention relates to a method for manufacturing a non porous film intended to be implanted in the human body, said method comprising the following steps: preparation of a first film, called intermediate film, via gelling of a starting solution comprising at least one polymer selected in the group consisting of collagen, glycosaminoglycans, and mixtures thereof, immersion of said intermediate film in an alkaline composition comprising at least one C | 2017-06-15 |
20170165400 | NATIVE SOFT TISSUE MATRIX FOR THERAPEUTIC APPLICATIONS - A method is used for preparing a product for use in repairing a lesion or defect at a tissue site in a human or animal patient body. The method includes obtaining tissue from a donor human or animal body and freezing the obtained tissue. The method further includes pulverizing the frozen tissue and suspending the pulverized tissue in a fluid. The method further includes homogenizing the tissue suspension and precipitating tissue particles from the homogenized tissue suspension. The method further includes re-suspending the precipitated tissue particles and lyophilizing the tissue re-suspension to provide the product to be used in repairing the lesion or defect. | 2017-06-15 |
20170165401 | VARIABLE DENSITY TISSUE GRAFT COMPOSITION AND METHODS OF MAKING AND USING THE SAME - Disclosed are tissue graft compositions made of materials having different densities, methods of making and methods of treatment for restoring tissues in a patient. | 2017-06-15 |
20170165402 | METHODS AND SYSTEMS FOR STIFFENING OF TISSUE FOR IMPROVED PROCESSING - Methods and systems for stiffening of tissue are presented to allow improved processing. Solutions comprising an acid or a base can be contacted with tissue to stiffen one or more components of the tissue. The resulting stiffened tissue can be used in the creation of wound treatment devices. | 2017-06-15 |
20170165403 | COMPOSITE BIOMATERIALS WITH IMPROVED BIOACTIVITY AND THEIR USE FOR BONE SUBSTITUTE - The present invention concerns composite biomaterials comprising ceramic and a biodegradable polymer gel, with improved bioactivity, their process of preparation and their use for orthopedics, dentistry or reconstructive surgery, in particular for use as a bone filler. | 2017-06-15 |
20170165404 | MODIFIED STARCH MATERIAL OF BIOCOMPATIBLE HEMOSTASIS - A modified starch material for biocompatible hemostasis, biocompatible adhesion prevention, tissue healing promotion, absorbable surgical wound sealing and tissue bonding, when applied as a biocompatible modified starch to the tissue of animals. The modified starch material produces hemostasis, reduces bleeding of the wound, extravasation of blood and tissue exudation, preserves the wound surface or the wound in relative wetness or dryness, inhibits the growth of bacteria and inflammatory response, minimizes tissue inflammation, and relieves patient pain. Any excess modified starch not involved in hemostatic activity is readily dissolved and rinsed away through saline irrigation during operation. After treatment of surgical wounds, combat wounds, trauma and emergency wounds, the modified starch hemostatic material is rapidly absorbed by the body without the complications associated with gauze and bandage removal. | 2017-06-15 |
20170165405 | SYSTEMS AND METHODS FOR APPLYING REDUCED PRESSURE THERAPY - Embodiments of a negative pressure wound therapy systems and methods for operating the systems are disclosed. In some embodiments, a system includes a pump assembly, canister, and a wound dressing configured to be positioned over a wound. The pump assembly, canister, and the wound dressing can be fluidically connected to facilitate delivery of negative pressure to a wound. The pump assembly can present graphical user interface screens for controlling and monitoring delivery of negative pressure. The system can be configured to efficiently deliver negative pressure and to detect and indicate presence of certain conditions, such as low pressure, high pressure, leak, canister full, and the like. Monitoring and detection of operating condition can be performed by measuring one or more operational parameters, such as pressure, flow rate, and the like. | 2017-06-15 |
20170165406 | PRESSURE CONTROL METHOD AND SYSTEM THEREOF - Disclosed is a pressure control method capable of performing wound treatment by using a cover unit, a tube member and a pressure control module, the method comprising: (a) the pressure control module forming a pressure having a first pressure value at the wound via the tube member and the cover unit; (b) within a first period of time, increasing the pressure from the first pressure value to a second pressure value; (c) within a second period of time, decreasing the pressure from the second pressure value to a third pressure value; (d) after the pressure has been increased from the third pressure value to a target pressure value, the pressure control module stopping increasing the pressure; (e) sampling a value from the pressure to form a sampled pressure value; and (f) according to the sampled pressure value, determining whether to perform a pressure boost process or perform step (e). | 2017-06-15 |
20170165407 | BLOOD PUMP WITH RESTART LOCKOUT - A control circuit includes a pump shutdown module responsive to one or more inputs indicating at least from the group consisting of an operational error at the implantable blood pump and an adverse physiological state of a user of the implantable blood pump. The pump shutdown module ceases operation of the implantable blood pump in response to the one or more inputs. A pump restart module configured to resume operation of the implantable blood pump in response to a first pump restart input and a second pump restart input is included. A pump restart lockout module configured to initiate a pump lockout mode in response to a lockout input is included. The pump lockout mode prevents resumption of operation of the implantable blood pump in response to the first pump restart input and allows resumption of operation of the implantable blood pump in response to the second pump restart input. | 2017-06-15 |
20170165408 | VENTRICULAR ASSIST DEVICE FOR INTRAVENTRICULAR PLACEMENT - A ventricular assist device includes a pump such as an axial flow pump, an outflow cannula connected to the outlet of the pump, and an anchor element. The anchor element is physically connected to the pump, as by an elongated element. The pump is implanted within the left ventricle with the outflow cannula projecting through the aortic valve but desirably terminating short of the aortic arch. The anchor element is fixed to the wall of the heart near the apex of the heart so that the anchor element holds the pump and outflow cannula in position. | 2017-06-15 |
20170165409 | HEAT BALANCE TYPE CIRCULATING PIPE SYSTEM - A heat-balance-type circulating pipe system, comprising a control system connected with a circulating hyperthermal perfusion heating device and a perfusion device; the circulating hyperthermal perfusion heating device comprises molecular rings, a plurality of magnetic field generators for heating a heating tank, an induction ring and a heater consisting of inductors; the inlet and the outlet connecting member of the perfusion device are communicated and then connected to the infusion member through a three-way joint; the inlet and the outlet connecting member are respectively connected with the heating tank; the heating tank comprises an outer and an inner tank; the inner heating tank is internally provided with an inner stirrer and an upper heating tank covered with a temperature control and detection sensor. The heat exchange efficiency is high; the hyperthermic perfusion therapeutic effect is good; and quick and uniform heat effect is good. | 2017-06-15 |
20170165410 | DEVICES AND METHODS FOR CONTROLLING BLOOD PERFUSION PRESSURE - Devices and methods for controlling blood perfusion pressure. In an exemplary device for controlling blood perfusion pressure within a vessel of the present disclosure, the device comprises an elongated body having a lumen, a proximal end configured for placement in a first area having a first blood pressure, and a distal end configured for placement in a second area having a second blood pressure, partial occluder positioned within the lumen of the elongated body between the proximal end and the distal end, the partial occluder configured so not to fully occlude a blood vessel, wherein the partial occluder is configured to equalize the first blood pressure at the first area with the second blood pressure at the second area. | 2017-06-15 |
20170165411 | Vaginal Hygiene Assembly - A vaginal hygiene assembly for cleaning and disinfecting a vaginal canal includes a bulb that may contain a solution. The bulb has an elongated neck and the elongated neck may be inserted into a vaginal canal. The bulb is comprised of a resiliently compressible material. Thus, the bulb may be manipulated thereby facilitating the solution to be urged into the vaginal canal. | 2017-06-15 |
20170165412 | INFUSION PUMP SMART PROGRAMMING - Methods, computer systems and computer readable media provide validation of one or more infusions for a patient without requiring barcode scanning. In embodiments, identification that a clinician has entered a room with one or more infusions is received based on proximity information. The room is associated with a patient that has orders for the one or more infusions. The clinician is automatically logged into an electronic medical record (EMR) associated with the patient, including context based on the clinician entering the room with the one or more infusion. As a result, the one or more infusions are automatically validated for the patient. | 2017-06-15 |
20170165413 | INFUSION PUMP LINE CONFIRMATION - Methods, computer systems and computer readable media cause an infusion pump to provide visual confirmation of line checks. In embodiments, an indication is provided that one or more infusions need a line check. A selection of on the one or more infusion is received. Information corresponding to the selection of the one of the one or more infusions is received from an electronic medical record (EMR) and communicated to a corresponding infusion pump. The infusion pump then provides a visual indication of the line check. | 2017-06-15 |
20170165414 | SELF-COMPENSATING CHUCKING DEVICE FOR INFUSION PUMP SYSTEMS - A self-compensating chucking device may be provided. The chucking device may form a portion of a latching door handle of a door of an infusion pump. The door and a housing of the infusion pump may form a clam-shell clamp that secures infusion tubing to pumping mechanisms of the infusion pump. The latching door handle may include a latching door mechanism that includes a tapered pin. The tapered pin may extend through an outer portion of a door housing, an opening in a handle of the door, and into an opening in an inner portion of the door housing. The opening in the handle of the door may have a tapered inner surface that corresponds to the taper the tapered pin to form the chucking device. The pin may include a groove configured to accept an E-clip that retains the tapered pin within the door housing. | 2017-06-15 |
20170165415 | SYSTEM AND METHOD FOR A SYRINGE MICRO PUMP WITH VOLUTE SPRING - Provided is a system and method for a removable syringe micro pump. More specifically, the removable syringe micro pump includes a pump housing having a first end and opposite thereto an attaching end, and at least one sidewall there between, the housing having a base proximate to the first end and, the attaching end having an attacher structured and arranged to temporarily engage a syringe. A volute spring is nested within the housing and attached proximate to the base, the volute spring having a compressed first position wherein coils of the volute spring are concentrically disposed under tension such that an initial height of the volute spring is equivalent to a width of a coil, and an extended second position wherein the release of tension extends the volute spring normally away from the pump housing. The volute spring has a diameter pre-selected to pass within a barrel of the engaged syringe. The volute spring further having a distal end structured and arranged to engage a plunger seal of the engaged syringe, wherein the release of tension between the first position and the second position permits the distal end of the volute spring to move the plunger seal towards a nozzle of the syringe. An associated method of use is also provided. | 2017-06-15 |
20170165416 | METHOD AND DEVICE UTILIZING INSULIN DELIVERY PROTOCOLS - A device for infusing liquid medicaments such as insulin includes an infusion pump. The device can modify an insulin delivery protocol stored in memory to delivery an alternative insulin delivery protocol with the pump. | 2017-06-15 |
20170165417 | SAFETY NEEDLE ASSEMBLIES AND RELATED METHODS - The safety needle assembly comprises a housing including a proximal end and a distal end and defining an interior space. A barrel is rotatably received within the interior space of the housing. A needle hub is received within the proximal end of the housing. A needle, including a sharp distal tip, extends distally from the needle hub, through the barrel, and through the distal end of the housing. A safety shield defining a lumen is received within the interior space of the housing. The safety shield extends distally from the housing through the distal end of the housing. The needle extends through the lumen of the safety shield with the sharp distal tip exposed from the safety shield. A biasing member is received within the barrel and extends between the needle hub and the safety shield. The safety needle assembly includes a first configuration in which the safety shield and the barrel define a first relative rotational orientation, and a second configuration in which the safety shield and the barrel define a second relative rotational orientation. | 2017-06-15 |
20170165418 | NEEDLE FOR ADMINISTERING A FLUID | 2017-06-15 |
20170165419 | SUBCUTANEOUS INFUSION DEVICE FOR INJECTING MEDICINAL SUBSTANCES - A medical delivery device is provided for delivering a medicinal substance into a user's body. A foldable hub has a left wing and a right wing, where the hub is attached at one end to a tube, and at an opposite end to a needle. At least one first rib is disposed on the left wing and at least one second rib is disposed on the right wing. When the wings are folded back away from the needle and pinched together, the first and second ribs prevent twisting and/or sliding of the wings relative to each other during an insertion of the needle into a user's skin, thereby preventing a breakage of the needle due to undesirable movement of the wings. | 2017-06-15 |
20170165420 | SUBCUTANEOUS HYDRATION SYSTEM, METHOD, AND DEVICE - Systems, methods, and devices for providing subcutaneous hydration are disclosed. A system for providing subcutaneous hydration may include an infusion bag including a hydration fluid, a tubing removably connected to the infusion bag, a squeezable bulb at least partially encompassing the tubing for at least one of flushing and priming the tubing, and a deployment device including an integrated needle which provides subcutaneous hydration through the needle. A deployment device for subcutaneous hydration includes a base having a needle aperture, a casing attached to the base, a firing mechanism within the casing for deploying a needle from the casing, and at least one wing attached to the base that includes an actuator that regulates the firing mechanism. A method for providing subcutaneous hydration may include steps necessary to operate the systems and devices for subcutaneous hydration. | 2017-06-15 |
20170165421 | DEVICES AND METHODS FOR PROTECTING A USER FROM A SHARP TIP OF A MEDICAL NEEDLE - There are disclosed devices and methods for protecting a user from a sharp tip of a medical needle. In an embodiment, a device includes a central body portion, a medical needle having a sharp tip, a pair of wings in attachment to the central body portion, and a hook-and-loop fastening system disposed on at least one of the wings, and configured to selectively attach the wings together with the medical needle positioned between the wings so as to protect a user from the sharp tip of the medical needle. In another embodiment, a method includes withdrawing a sharp tip of a medical needle from a patient, closing a pair of wings with the medical needle positioned between the wings, and fastening the wings together with the medical needle positioned between the wings so as to protect a user from the sharp tip of the medical needle. | 2017-06-15 |
20170165422 | Needle Shielding Assemblies and Infusion Devices for Use Therewith - A needle assembly includes a needle and a needle shield device. The needle shield device includes an inner shield connectable to at least one a base and a fluid connector connectable to the base, and an outer shield fixedly connected to the opposing end the needle and displaceable relative to the inner shield between a first position, in which the sharpened end of the needle is exposed outside the inner shield, and a second position, in which the sharpened end of the needle is shielded by the inner shield. Interaction between portions of the inner and outer shields during or after proximal displacement of the outer shield from the first position to the second position automatically releases or permits release of the inner shield from connection to the at least one of the base and the fluid connector. | 2017-06-15 |
20170165423 | SAFETY SYRINGE - A safety syringe ( | 2017-06-15 |
20170165424 | VETERINARY SYRINGE FOR MULTIPLE INJECTIONS - A trigger operated syringe ( | 2017-06-15 |
20170165425 | SYSTEMS AND METHODS FOR DETERMINING INSULIN THERAPY FOR A PATIENT - In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage. | 2017-06-15 |
20170165426 | AUTOINJECTOR - An autoinjector having a reservoir containing fluid and including: a piston; a piston rod cooperating with the piston and is movable between a rest position and an injection position in which the piston rod has moved the piston to inject the fluid; an actuator spring urging the piston rod towards its injection position; a force-adjustment system exerting at least one force on the piston rod, the force adding to the force exerted by the spring on the piston rod at the beginning of injection; two pivot members cooperating with the piston rod and are connected together by two resilient elements, at least one pivot member being blocked prior to actuation by a locking system, thus preventing the autoinjector from being actuated, and an unlocking element adapted to move and/or to deform the locking system so as to unblock the at least one pivot member. | 2017-06-15 |
20170165427 | SYRINGE AND FLUID INJECTION SYSTEM WITH AN ORIENTATION INDEPENDENT IDENTIFICATION CODE - A syringe is provided including an orientation independent indicia that can be used to validate and determine information about the syringe, injection parameters, and/or fluid contained therein. The syringe includes a syringe barrel and an indicia located on a portion of the syringe containing or associated with identifying information about the syringe, one or more injection parameters of a fluid injector, or a fluid filled in the syringe barrel. The indicia is readable by a reader independent of an orientation of the syringe relative to the reader. A fluid injection system for providing fluid into a patient is also provided. The injection system includes the syringe having an orientation-independent indicia, an injector having at least one syringe receiving port for receiving the syringe, and a controller. The controller can be configured to obtain information from the indicia and provide instructions for performing injections to the injector, based on the information. | 2017-06-15 |
20170165428 | MEDICAMENT DELIVERY DEVICE WITH DELIVERY FINISH SIGNAL DELAY - A medicament delivery device is present having comprising: a housing with a distal and an proximal end, the housing being adapted to receive a medicament container with a delivery member or with a connectable delivery member for delivery of a medicament. A drive mechanism is arranged to act on the medicament container for providing automatic delivery of the medicament. An actuator is interactively connected to the drive mechanism for holding the drive mechanism in a pre-tensioned state. There is a biased delivery member cover that is positioned at least partially and axially movable within the housing, where the biased delivery member cover is interactively connected to the actuator, such that when the biased delivery member cover is pressed against a delivery site the actuator releases the drive mechanism from the pre-tensioned state. Also included is a signal delay mechanism operably connected to said drive mechanism for generating an audible and/or tactile and/or visual signal indicating that the medicament has been completely delivered. | 2017-06-15 |
20170165429 | Medicament Delivery Device and Method of Assembling the Same - A device for injection of a medicament includes a housing having distal and proximal end openings; a needle guard extending from the proximal end opening and movable relative to the housing from an extended position to a retracted position, in which the needle guard is biassed toward the extended position; an activation member extending from the distal end opening and movable relative to the housing from an initial position to a final position; a lock that restricts movement of the activation member in the final position; and a needle guard lock that restricts movement of the needle guard from the extended position to the retracted position when the activation member is in the final position. A method of assembling the medicament delivery device is also disclosed. | 2017-06-15 |
20170165430 | Housing for a drug delivery device and drug delivery device - The invention is directed to a housing ( | 2017-06-15 |
20170165431 | Automatic Injection Device with a Top Release Mechanism - The present invention relates to a handheld mechanical injection device by which set doses of a liquid medicament can be injected from a medical reservoir. The medicament is expelled through an injection needle by release of a power reservoir in the device, the power reservoir being fully or partially released by actuation of a user operable release member being positioned at or near an upper end of the injection device, the upper end being that end of the injection device which is opposite the injection needle. | 2017-06-15 |
20170165432 | SELECTABLE NEEDLE SYRINGE WITH RETRACTION PLUNGER - The present embodiments provide for a syringe and a retraction plunger assembly configured to accept various retractable needle assemblies, which are capable of cooperating to provide a retraction safety syringe. In particular, the syringe includes a barrel and a retraction plunger assembly comprising a control unit attached to a plunger and releasably engaged to a housing, and at least one biasing means disposed within the plunger assembly. Upon completion of dose delivery via a retractable needle, the control unit disengages from housing and the biasing member retracts the plunger and a connected needle into the barrel. Various elements are configured to prevent further use of the syringe. The control unit can be used to control a rate of needle retraction. | 2017-06-15 |
20170165433 | MEDICAMENT DELIVERY DEVICE - A medicament delivery device is presented having a housing configured to receive a medicament container having a delivery member and a shield, a protective cap, and wherein the protective cap comprises connecting means for connecting to the shield of the medicament container such that removal of the protective cap from the housing causes removal of the shield from the medicament container. The delivery device is characterised in that a protective cap assembly has a first disconnecting means configured to interact with corresponding second disconnecting means of the housing and of the protective cap such that activation of the first disconnecting means of the protective cap assembly causes the displacement of the protective cap relative to the housing. | 2017-06-15 |
20170165434 | MULTI-NEEDLE NEEDLE ASSEMBLY - A multi-needle needle assembly includes a multi-needle body, a box, and a needle length adjustment mechanism. The multi-needle body is disposed in the box. The multi-needle body includes a plurality of needles and a connecting opening for connecting an automatic auxiliary device, such that the effect of full-thickness skin injection can be achieved to save injection time. | 2017-06-15 |
20170165435 | GAS REMOVAL SYSTEMS AND METHODS - An air removal device for an intravenous fluid system includes a housing with an inlet for fluid communication with a fluid source, a fluid outlet for fluid communication with a blood vessel of a patient, and an air outlet. The air removal device further includes a disrupting element disposed within the housing in a flow path between the inlet and the fluid outlet, and an air chamber in fluid communication with the air outlet. The disrupting element includes a protrusion extending across the flow path. The flow path includes a first cross-sectional flow area at the inlet, and a second cross-sectional flow area at the protrusion. The second cross-sectional flow area is smaller than the first cross-sectional flow area. | 2017-06-15 |
20170165436 | SYSTEM FOR DETECTING AND REMOVING A GAS BUBBLE FROM A VASCULAR INFUSION LINE - A system for detecting and removing a gas bubble from a vascular infusion line, the system comprising:
| 2017-06-15 |
20170165437 | TAMPER-RESISTANT ENCLOSURES FOR FLUID LINES - A tamper-resistant device for holding a portion of an access port of a fluid line can include a first housing member that includes a first recess and a first stopping shelf. The device can further include a second housing member that includes a second recess and a second stopping shelf. The second housing member can couple with the first housing member such that the first and second stopping shelves cooperate to retain the portion of the access port within the device. The device can include a locking mechanism configured maintain the first and second housing members in a coupled state when engaged. The device can further include a tamper-evident indicator that, when activated, permits the first and second housing members to transition from the coupled state to a decoupled state to permit access to the access port of the fluid line. | 2017-06-15 |
20170165438 | Single Use Atomizer Designed To Minimize Chances of Contamination - The single use atomizer retains the look, feel, heft, and operation of the multi-use atomizers preferred by most doctors by replacing the standard multi-dose reservoir with a modified reservoir and shortening the inlet tube. The modified reservoir is equipped to accept a single-dose receptacle and with means to associate the single-dose receptacle with the standard nozzle, applicator, and trigger. | 2017-06-15 |
20170165439 | ACTIVE DRY POWDER INHALER - A method of flowing a medicament comprising dry powder using gas, including preparing a medicament capsule with designated inflow and outflow apertures, introducing a volume of a gas to within a medicament capsule according to one or more release conditions, and releasing a therapeutically effective amount of said powder using said gas. In some embodiments, the medicament capsule apertures are prepared and/or gas delivered to it so that deagglomeration potentially occurs largely within the energetic flow conditions of the capsule, without significant trapping of residual powder by structures such as aperture edge irregularities. | 2017-06-15 |
20170165440 | Integrated, Extendable Anesthesia System - The specification describes anesthesia systems with an integrated, extendable clinical center and clinician/anesthesia office that accommodates for physical separation of clinical and clerical functions. The disclosed anesthesia systems allow for a portion of the system to be brought closer to the patient such that clinical controls can be accessed while tending to the patient airway, without compromising office space available to the clinician or crowding the patient area. | 2017-06-15 |
20170165441 | ENDOTRACHEAL TUBE HAVING OUTER AND INNER CANNULAE - A tracheal tube apparatus includes a cannula having first and second ends. An inflatable cuff is formed on the cannula between the first and second ends. A conduit extends from the cuff for introducing an inflating fluid into the cuff when it is desired to inflate the cuff and removing inflating fluid from the cuff when it is desired to deflate the cuff. A gauge for indicating the inflation pressure of the cuff is coupled in the conduit. | 2017-06-15 |
20170165442 | PERFORATED FACE MASK FOVE FENESTRATED CPAP ORAL VENTILATION ELIMINATOR - The face support mask for respiratory conditions of the first preferred embodiments consists of a piece of flexible material with at least two perforations positioned so that they will be over the mouth of a user, where the piece of flexible material is attached to a releasable coupler on both lateral sides, where the releasable couplers are designed to releasably attach the piece of flexible material to lateral face straps. The face support mask for respiratory conditions of the preferred embodiments is preferably designed to apply restraining pressure to a user's lips and cheeks to prevent air from escaping from a user's mouth while they are sleeping, while also allowing the user to sigh, make noise, sneeze, cough, move their mouth or carry out other intentional actions while they are wearing the face support mask and are awake. | 2017-06-15 |
20170165443 | SYSTEMS, METHODS, AND DEVICES FOR OZONE SANITIZATION OF CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES - The present invention is generally related to a device and method for sanitizing a medical instrument with ozone, in particular the invention relates to a system, method and a device for sanitizing a continuous positive airway pressure (CPAP) device. The device has an ozone compartment, an ozone operating system and one or more ozone distribution lines that distribute ozone to a continuous positive airway pressure device. The device may further include a heater adapter unit to connect heating systems in CPAP devices while distributing ozone to sanitize the CPAP device in accordance with the present invention. | 2017-06-15 |
20170165444 | PAP SYSTEM - A PAP system adapted for treatment of respiratory disease or sleep disordered breathing includes headgear adapted to engage a patient's head, a patient interface adapted to be secured to and sealed against a portion of a patient's face, in use, by the headgear, a flow generator adapted to be connected to the patient interface, and wherein the flow generator is adapted to be secured by a portion of the headgear to the patient's head, and an outlet tube to interconnect the flow generator and the patient interface. The patient interface includes a frame and a sealing arrangement supported by the frame. The sealing arrangement includes a seal portion, a body portion, and an inlet tube in communication with the outlet tube. The frame and the outlet tube are constructed of a relatively rigid material. | 2017-06-15 |
20170165445 | PERSONALIZED FORCED AIR PURIFIER - The present invention is a portable air purifier device intended to be attached to the belt or to the neck of the user and generate purified air enough to breath easily and adequate to make an air curtain to push a way ambient air. Principle of the operation of this device is to push inlet polluted air through layers of ionized water. Water will absorb particles and copper and silver ion kills possible air born bacteria and produce clean air. The purified air will be then delivered to the face of the user either by a flexible hose to a mask or through several flexible hoses to form an air curtain in front of a user's face. | 2017-06-15 |
20170165446 | Medical Carbon Monoxide Delivery System - A medical carbon monoxide generator provides for a solid carbon material that may be heated at substantially normal atmospheric pressure to provide a source of medical quality carbon monoxide. The heating source may be an electrical filament or laser controllable by a microcontroller to provide accurate delivery rates and amounts. In one embodiment, a replaceable cartridge holding the carbon material may be used. | 2017-06-15 |
20170165447 | METHOD AND APPARATUS FOR ADMINISTERING GASES INCLUDING NITRIC OXIDE - A method of modulating oxygen saturation levels can include measuring oxygen saturation levels in a patient, administering inhaled nitric oxide, adjusting the dose of oxygen in real time to a second dose based on the inhaled nitric oxide. | 2017-06-15 |
20170165448 | HIGH FLOW OF WARM HUMIDIFIED OXYGEN - The present invention relates to the administration of warm humidified oxygen to patients suffering with breathing problems. The present invention more specifically relates to the high flow of warm humidified oxygen to patients suffering with breathing problems or suffering with asthma. | 2017-06-15 |
20170165449 | BREATHABLE GAS INLET CONTROL DEVICE FOR RESPIRATORY TREATMENT APPARATUS - A breathable gas inlet control device permits flow regulation at the inlet of a flow generator for a respiratory treatment apparatus such as a ventilator or continuous positive airway pressure device. The device may implement a variable inlet aperture size based on flow conditions. In one embodiment, an inlet flow seal opens or closes the inlet to a blower in accordance with changes in pressure within a seal activation chamber near the seal. The seal may be formed by a flexible membrane. A controller selectively changes the pressure of the seal activation chamber by controlling a set of one or more flow control valves to selectively stop forward flow, prevent back flow or lock open the seal to permit either back flow or forward flow. The controller may set the flow control valves as a function of detected respiratory conditions based on data from pressure and/or flow sensors. | 2017-06-15 |
20170165450 | Continuous Transversus Abdominis Plane Block - A kit is provided for performing an ultrasound-guided transversus abdominis plane (TAP) procedure. The kit includes a container having a fluid delivery needle with a length and gauge for penetration into a patient's TAP. An extension set is included having a distal end that mates with the fluid delivery needle. A sheath is included having a size and length such that the needle slides into sheath and extends distally beyond a distal end of the sheath. A TAP catheter is included having a size and length so as to slide through the sheath. The TAP catheter has a reservoir with a defined fill volume and flow rate for delivery of a local anesthetic through said catheter. | 2017-06-15 |
20170165451 | INSERTION DEVICE WITH PROTECTION AGAINST REUSE - An insertion device ( | 2017-06-15 |
20170165452 | INSERTION DEVICE WITH SAFETY LOCK - The invention relates to an insertion device ( | 2017-06-15 |
20170165453 | Catheter Assembly Including a Multi-Lumen Configuration - A catheter assembly for use in accessing a vasculature of a patient is disclosed. In one embodiment, the catheter assembly includes a catheter body that includes a flattened oval outer surface and defines first and second lumens. The catheter body defines a distal tip region that includes a venous lateral opening that is in fluid communication with the first lumen and includes a distal-facing portion. The distal tip region further includes an arterial lateral opening that is in fluid communication with the second lumen, includes a distal-facing portion, and is substantially un-staggered with respect to the venous lateral opening. A distal end opening is in fluid communication with a power injectable third lumen. In another embodiment, the first and second lumens each generally include a reniform cross-sectional shape. In yet another embodiment, a dual-lumen catheter includes first and second lumens that each define a modified ellipse cross-sectional shape. | 2017-06-15 |
20170165454 | CATHETER WITH A LUMEN SHAPED AS AN IDENTIFICATION SYMBOL - A catheter includes a catheter shaft having a shaft wall and a lumen extending longitudinally within the shaft wall. The lumen is bounded in radially outward and radially inward directions. The lumen includes a feed portion and an identification symbol fluidly connected to the feed portion. The lumen is configured to receive a contrast media. The lumen may be formed by a channel formed in an outer surface of a first shaft of the catheter shaft, and a covering disposed around the outer surface of the first shaft to cover the channel. | 2017-06-15 |
20170165455 | MEDICAL SYSTEM - A medical system including: a plurality of medical instruments each including an elongated insertion section that can be inserted into the body from the body surface; fixing parts that are provided in the insertion sections of the plurality of medical instruments, respectively, at positions away from the distal ends toward the proximal end side and that can be coupled with or separated from each other; and manipulation parts that are provided at the proximal end side of the insertion sections and that are used to manipulate coupling and separation of the fixing parts. | 2017-06-15 |